SAFETY PROFILES OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS CAPTOPRIL AND ENALAPRIL

被引：78

作者：

IRVIN, JD

VIAU, JM

机构：

来源：

AMERICAN JOURNAL OF MEDICINE | 1986年 / 81卷 / 4C期

关键词：

D O I：

10.1016/0002-9343(86)90945-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：46 / 50

页数：5

共 12 条

[1] CAPTOPRIL-ASSOCIATED NEUTROPENIA - WHO IS AT RISK [J].

COOPER, RA .

ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (04) :659-660

[2] AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF ENALAPRIL [J].

DAVIES, RO ;

GOMEZ, HJ ;

IRVIN, JD ;

WALKER, JF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S215-S229

[3]

FERGUSON RK, 1977, LANCET, V1, P775

[4]

FERGUSON RK, 1983, CLIN PHARMACOL THER, V33, P254

[5]

FROLICH ED, 1984, ARCH INTERN MED, V144, P1441

[6]

Gomez H J, 1983, J Hypertens Suppl, V1, P65

[7] ENALAPRIL - A REVIEW OF HUMAN PHARMACOLOGY [J].

GOMEZ, HJ ;

CIRILLO, VJ ;

IRVIN, JD .

DRUGS, 1985, 30 :13-24

[8] ADVERSE-EFFECTS PROFILE OF SULFHYDRYL COMPOUNDS IN MAN [J].

JAFFE, IA .

AMERICAN JOURNAL OF MEDICINE, 1986, 80 (03) :471-476

[9]

JENKINS AC, 1985, CARDIOVASC PHARM S1, V7, P596

[10]

PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0

← 1 2 →